London-based HealthTech company, Semble has raised $15m in a Series B funding round led by Mercia Ventures.
The tranche managed to land a swathe of investors with additional support coming in droves from Octopus Ventures, Smedvig Ventures, and Triple Point.
With this latest funding, Semble intends to solidify its UK market presence while expanding into France, where it recently launched.
The investment will fuel advancements in automation and AI-powered features, allowing Semble to cater to both small and large healthcare operators as they move towards a more digitised healthcare framework.
Semble CEO Christoph Lippuner explained, “Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem.”
The firm’s platform aims to modernise the healthcare sector by providing automation and integration solutions tailored to healthcare operators of all sizes.
Founded by Lippuner alongside Mikael Landau, a pair of experienced entrepreneurs who exited a prior start-up, Semble seeks to alleviate the administrative burdens on medical professionals by creating a connected ecosystem that enhances patient outcomes.
Semble’s clinical system allows for secure data exchange with third-party entities, such as hospitals and pharmacies, and automates essential tasks, making it a comprehensive tool for healthcare providers.
In the UK, healthcare practitioners continue to rely on outdated technology, which has led to a significant strain on resources.
According to a British Medical Association report, outdated IT infrastructure costs doctors in England an estimated 13.5m working hours annually. Semble’s all-in-one platform seeks to address this, providing adaptability for healthcare professionals to deliver patient care more efficiently.
Alex Gwyther of Mercia Ventures commented on the investment, saying, “The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future. Semble is pioneering an all-in-one clinical system that enables healthcare businesses to automate many aspects of their practice. This investment will help Semble accelerate product development and expand its presence in the UK and France, empowering healthcare organisations to deliver on their digital transformation and transform their patients’ experience. With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity.”
This Series B funding brings Semble’s total funding to $27m. The company, currently employing around 80 people, focuses over half its workforce on product development, driving both revenue and customer growth as it prepares for the next stage in its expansion.
Keep up with all the latest FinTech news here.
Copyright © 2024 FinTech Global
